sulopenem etzadroxil and probenecid
IT001-109
Phase 1 small_molecule active
Quick answer
sulopenem etzadroxil and probenecid for Pharmacokinetics After Oral Intake is a Phase 1 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iterum Therapeutics plc
- Indication
- Pharmacokinetics After Oral Intake
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active